Development of blood clots following long-haul flights prevented with single dose of enoxaparin sodium

November 13, 2001

Chieti, Italy, London , UK - Deep-vein thrombosis (DVT) and pulmonary embolism, the potentially life-threatening disorders in which blood clots form primarily in the legs, were prevented in long-haul airline travelers with a history of heart disease through a single dose of the widely prescribed antithrombotic agent enoxaparin sodium (Clexane(R)/Lovenox(R)), according to a new study. The San Valentino Screening Project (the Italian equivalent of the well-known Framingham Heart Study) organised the study known as LONFLIT III. The entire LONFLIT research program includes more than 1500 subjects, each of whom experienced a flight of at least 10 hours in length.

LONFLIT III, an independently funded study, enrolled 300 people with a history of heart disease or stroke who were subsequently subjected to a plane flight of more than 10 hours in duration. Study participants were randomly assigned to receive either 400 mg of aspirin in one daily dose for three days (starting 12 hours before their flight), a single weight-adjusted dose (0.1 ml per 10 Kgs) of enoxaparin 2-4 hours prior their flight, or no preventive treatment. There were 52 patients who failed to complete the study after randomization and they were equally represented from among the three groups.

Among the 82 people receiving enoxaparin prior to their flights, there were no cases of DVT, and only one superficial clot (p<.002 in comparison with the other two groups). However, in the aspirin group, 3.6 percent of the 84 subjects had DVT, along with two superficial clots (p<.025), and in the no treatment control group, 4.8 percent of the 82 participants had DVT, along with two superficial clots. Participants underwent ultrasound scans within 24 hours before and after the flights to determine if DVT had occurred.

"These data suggest that a single dose of enoxaparin is an important consideration for high risk patients prior to a prolonged flight," said researcher Gianni Belcaro, PhD., of the University of Chieti in Chieti, Italy. "The dose of enoxaparin needed is low and can be easily injected into the subcutaneous tissue by the patient. Clearly, it should be prescribed for high-risk patients." The high-risk profile included those who had previous incidences of thrombosis, blood-clotting problems and circulatory problems in the legs, and coagulation disorders where high risk for DVT is well established.

The LONFLIT III study was funded by the San Valentino Vascular Screening Program, Italian Society for Vascular Investigations, European Venous Forum International Union of Angiology and University Funds. The study was conducted by an international group of researchers from the United Kingdom, Australia and Italy, and led by Dr. Belcaro. The results of this study were presented today at the American Heart Association's Scientific Sessions 2001 conference, one of the world's largest annual cardiology research meetings.

The previously conducted LONFLIT I study was designed to evaluate the occurrence of DVT as a consequence of long-haul flights. That study showed that no cases of DVT developed among 355 low-risk people, but that 19 of 389 high-risk people had blood clots (13 having DVT and 6 having superficial clots). The LONFLIT II study documented the effectiveness of wearing compression stockings as a way of preventing DVT in low-risk people. In this study, the incidence of DVT observed in subjects wearing compression stockings was 18.75 times lower than in the group who did not wear the stockings.

"Sitting in a cramped airplane seat for hours on end could result in a blood clot in a vein," said Belcaro. "Lack of mobility is the reason for the clot, but low pressure in the airplane cabin, low humidity and dehydration may also be contributing factors."
-end-
Contact:G Belcaro, MR Cesarone Dep Biomedical Sciences, Irvine2 Vasc Lab, GD'Annunzio University, Chieti, Italy, Ealing Hospital, Vascular Unit, St Mary's Hospital-Imperial College, London & Other Institutions
San Valentino 0039 085 8574944 cardres@pe.abol.it Corso Umberto I, 18, San Valentino, 65020 Pe, Italy

MCS

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.